Douglas Pharmaceuticals launches into $100m investment programme
New marketing subsidiary established in the US.
Graham Skellern
Tue, 23 Apr 2019
Auckland-based Douglas Pharmaceuticals has begun construction of a new $35 million research and development (R&D) facility as the family-owned business continues a strong growth phase.
The company, established by pharmacist Graeme Douglas in 1967, is fast running out of space for its growing
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Graham Skellern
Tue, 23 Apr 2019
Contact the Writer: graham@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Douglas Pharmaceuticals launches into $100m investment programme
Business,Investment,
78973